There's a big question in terms of if we've got people with any sort of LDL cholesterol level that's in this range where atherosclerosis can progress, is kicking the con down the road by a decade. I think there's a big ethical question that will eventually have to be faced where delaying intervening in the causal pathway could lead to some very bad outcomes for patients. The three major class of drugs that are available for lowering LDL include statins which inhibit HMG-CoA reductase and Zetamib on bile acids sequestrant. And they all act by upregulating the expression of the LDL receptor. They all act by making more cranes in the harbor clear

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode